Prostate Cancer Clinical Trial

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

Summary

The purpose of this study is to find out the effects of exercise therapy on indicators of prostate cancer in people with low-risk prostate cancer who are on active surveillance. The exercise therapy in this study will be regular home-based walking sessions on a treadmill, and that therapy will be assigned by an exercise physiologist (a medical professional who studies how exercise affects the human body). Some participants in this study will have the assigned exercise therapy, and some participants will participate in their usual exercise routines. Researchers will compare how the assigned exercise therapy and the usual exercise routines affect indicators of prostate cancer in participants. This study will not provide treatment for prostate cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age ≥ 18
Men with histologically confirmed localized prostate cancer undergoing active surveillance.
Inactive, defined as not meeting the national exercise guidelines for cancer patients (<150 minutes/week of moderate or vigorous exercise)43 as assessed by remote activity and heart rate tracking for a 7-day period prior to study entry (general physical activity screening assessment via smart watch).
Screening clearance by an MSK Exercise Physiologist (i.e., review of ECG and PAR-Q)
BMI <40 kg/m^2

Exclusion Criteria:

Enrollment in any other program that may alter the impact of exercise on tumor outcomes (e.g., weight loss program)
Any neoadjuvant anticancer treatment of any kind for prostate cancer in the last 5 years
Any history of systemic anticancer therapy in the last 15 years
Distant metastatic malignancy of any kind
Any other condition or intercurrent illness that, in the opinion of the investigator, makes the subject a poor candidate for study participation

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

102

Study ID:

NCT05751434

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

University of California, Los Angeles (Data and Specimen Analysis Only)
Los Angeles California, 90095, United States More Info
Paul Boutros, PhD
Contact
310-794-7160
Jaron Arbet, PhD
Contact
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge New Jersey, 07920, United States More Info
Lee Jones, PhD
Contact
646-888-8103
Memorial Sloan Kettering Monmouth (Limited protocol activities)
Middletown New Jersey, 07748, United States More Info
Lee Jones, PhD
Contact
646-888-8103
Memorial Sloan Kettering Bergen (Limited protocol activities)
Montvale New Jersey, 07645, United States More Info
Lee Jones, PhD
Contact
646-888-8103
Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities)
Commack New York, 11725, United States More Info
Lee Jones, PhD
Contact
646-888-8103
Memorial Sloan Kettering Westchester (Limited protocol activities)
Harrison New York, 10604, United States More Info
Lee Jones, PhD
Contact
646-888-8103
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York New York, 10065, United States More Info
Lee Jones, PhD
Contact
646-888-8103
Memorial Sloan Kettering Nassau (Limited protocol activites)
Rockville Centre New York, 11553, United States More Info
Lee Jones, PhD
Contact
646-888-8103

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

102

Study ID:

NCT05751434

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.